About


Vesper is a biotech focused Venture Builder Fund

Vesper supports transformative and truly disruptive biotechnology projects, by providing access to capital from our own investment funds and third-party capital, national and international network and, above all, through hard work and a dedicated management team.

We create disruptive startups focused on major global challenges. We bring together world-class scientists and brilliant entrepreneurs to create technology platforms that bring significant advances to therapeutics, diagnostics, food production and environmental sectors.

At VESPER, we believe that companies can only be truly successful in a thriving society and on a healthy planet.


What we do

VESPER focuses on quality and not quantity, therefore, our selection process is very rigorous. We stand out for our hands-on, participatory and collaborative management style. Our main expertise are:

The search, selection and evaluation of projects characterized by their high technical and scientific level.

The search, selection and evaluation of projects characterized by their high technical and scientific level.

Mastery of the processes in evaluation and protecting intellectual property at a global level.

Mastery of the processes in evaluation and protecting intellectual property at a global level.

The creation of assertive strategic plans that are adequate to the reality within the Biotech universe.

The creation of assertive strategic plans that are adequate to the reality within the Biotech universe.

Project management.

Project management.

Raising financial resources, nationally and internationally.

Raising financial resources, nationally and internationally.

International expansion.

International expansion.



How we do it

  • 01.
    Selection

    Evaluation and selection of proposals, team, level of disruption and robustness of intellectual property.

  • 02.
    Validation

    Protection and technology validation in the laboratory / pre-clinical phase with investments made by Vesper's own fund or in partnership with partner investors.

  • 03.
    Emancipation

    Field/ clinical validation through new investment rounds with funds of great strategic interest;

    Team expansion and the formation of a world-class board;

    Internationalization.

  • 04.
    Expansion

    Negotiations with strategic players, licensing or IPO/Exit.